CXCR3 and neoplasm: Tumor cell frequency was reduced by 60% after the transfer of IL-15-activated Cxcr3+/+ NK cells while it was reduced by more than 85% after the transfer of the Cxcr3−/− counterpart when compared to PBS-injected mice.